Article
CDKN2B gene rs1063192 polymorphism decreases the risk of glaucoma.
Oncotarget - 28 Mar 2017
Hu Zhenxian, He Chenliang
Abstract excerpt
The aim of this meta-analysis was to evaluate the association between cyclin-dependent kinase Inhibitor-2B (CDKN2B) gene rs1063192 polymorphism and glaucoma risk. We searched the databases of PubMed, and Embase. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by using fixed-effect or random-effect models. A total of 14 case-control studies involving 11,316 cases and 24,055 controls...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
